Disease Markers / 2020 / Article / Fig 1

Research Article

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma

Figure 1

FEN1 expression is frequently upregulated in cancers. (a) FEN1 mRNA expression in TCGA data analysis in cancers and paired normal tissues. (b) FEN1 protein expression in pan-cancer tissues and paired nontumor samples. FEN1 protein was upregulated in tumor tissues. (c) Representative FEN1 histologic scoring in pan-cancer tissues and paired nontumor samples. FEN1: flap endonuclease 1; HCC: hepatocellular carcinoma; TMA: tissue microarrays; GEO: Gene Expression Omnibus; TCGA: The Cancer Genome Atlas; GSEA: gene set enrichment analysis; ACC: adrenocortical carcinoma; BLCA: bladder urothelial carcinoma; BRCA: breast cancer; CESC: cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL: cholangiocarcinoma; COAD: colon adenocarcinoma; DLBC: lymphoid neoplasm diffuse large B-cell lymphoma; ESCA: esophageal carcinoma; GBM: glioblastoma multiforme; HNSC: head and neck squamous cell carcinoma; KICH: kidney chromophobe; KIRC: kidney renal clear cell carcinoma; KIRP: kidney renal papillary cell carcinoma; LAML: acute myeloid leukemia; LGG: brain lower-grade glioma; LIHC: liver hepatocellular carcinoma; LUAD: lung adenocarcinoma; LUSC: lung squamous cell carcinoma; MESO: mesothelioma; OV: ovarian serous cystadenocarcinoma; PAAD: pancreatic adenocarcinoma; PCPG: pheochromocytoma and paraganglioma; PRAD: prostate adenocarcinoma; READ: rectum adenocarcinoma; SARC: sarcoma; SKCM: skin cutaneous melanoma; STAD: stomach adenocarcinoma; TGCT: testicular germ cell tumor; THCA: thyroid carcinoma; THYM: thymoma; UCEC: uterine corpus endometrial carcinoma; UCS: uterine carcinosarcoma; UVM: uveal melanoma.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.